Cargando…
Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475559/ https://www.ncbi.nlm.nih.gov/pubmed/32944365 http://dx.doi.org/10.21037/jtd.2020.03.34 |
_version_ | 1783579532510363648 |
---|---|
author | Chan, Jack D. Harrison, Aaron J. Darcy, Phillip K. Kershaw, Michael H. Slaney, Clare Y. |
author_facet | Chan, Jack D. Harrison, Aaron J. Darcy, Phillip K. Kershaw, Michael H. Slaney, Clare Y. |
author_sort | Chan, Jack D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7475559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-74755592020-09-16 Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities Chan, Jack D. Harrison, Aaron J. Darcy, Phillip K. Kershaw, Michael H. Slaney, Clare Y. J Thorac Dis Editorial on Immunotherapy and Tumor Microenvironment AME Publishing Company 2020-08 /pmc/articles/PMC7475559/ /pubmed/32944365 http://dx.doi.org/10.21037/jtd.2020.03.34 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial on Immunotherapy and Tumor Microenvironment Chan, Jack D. Harrison, Aaron J. Darcy, Phillip K. Kershaw, Michael H. Slaney, Clare Y. Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title | Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title_full | Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title_fullStr | Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title_full_unstemmed | Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title_short | Chimeric antigen receptor T cell therapies for thoracic cancers—challenges and opportunities |
title_sort | chimeric antigen receptor t cell therapies for thoracic cancers—challenges and opportunities |
topic | Editorial on Immunotherapy and Tumor Microenvironment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475559/ https://www.ncbi.nlm.nih.gov/pubmed/32944365 http://dx.doi.org/10.21037/jtd.2020.03.34 |
work_keys_str_mv | AT chanjackd chimericantigenreceptortcelltherapiesforthoraciccancerschallengesandopportunities AT harrisonaaronj chimericantigenreceptortcelltherapiesforthoraciccancerschallengesandopportunities AT darcyphillipk chimericantigenreceptortcelltherapiesforthoraciccancerschallengesandopportunities AT kershawmichaelh chimericantigenreceptortcelltherapiesforthoraciccancerschallengesandopportunities AT slaneyclarey chimericantigenreceptortcelltherapiesforthoraciccancerschallengesandopportunities |